Fundz

Niimbl Announces $4.6M To Fund 10 New Biopharmaceutical Manufacturing Projects

PRIVATEJun 08, 2021

Amount Raised

$4.6 Million

Round Type

Seed

NewarkManufacturingBiotechnology

Description

The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) is pleased to announce funding for 10 new projects in technology, workforce development, and their Global Health Fund initiative, resulting from the Institute's Project Call 4.1, and with a total value of approximately $4.6M.

Quick answer

NIIMBL raised $4.6 Million in a Seed round, dated June 8, 2021. NIIMBL is based in Newark, New Jersey, United States.

How much did NIIMBL raise?
NIIMBL raised $4.6 Million in a Seed round on June 8, 2021.
What does NIIMBL do?
The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) is a public-private partnership whose mission is to accelerate biopharmaceutical innovation, support the development of standards that..
Where is NIIMBL based and how big is it?
NIIMBL is based in Newark, New Jersey, United States.

Source: Fundz verified event record.

Who else raised in Manufacturing and Biotechnology around the same time

Companies in the same sectors as NIIMBL that raised within 45 days of this round, from Fundz verified event records.

  • Microbix Biosystems Inc. raised an undisclosed amount on July 21, 2021.
  • Hadrian raised $6.1M on July 21, 2021.
  • Century Therapeutics raised $11M on July 19, 2021.
  • Omniscient Neurotechnology raised an undisclosed amount (Series B) on July 19, 2021.
  • Embody raised $11M on July 19, 2021.
  • Tenon Medical raised $12M on July 15, 2021.

Who to call at NIIMBL, and when

A new round usually means NIIMBL is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day NIIMBL raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at NIIMBL, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at NIIMBL. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

NIIMBL

Location

Newark, New Jersey, United States

About

The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) is a public-private partnership whose mission is to accelerate biopharmaceutical innovation, support the development of standards that enable more efficient and rapid manufacturing capabilities, and educate and train a world-leading biopharmaceutical manufacturing workforce, fundamentally advancing U.S. competitiveness in this industry. NIIMBL is part of Manufacturing USA®, a diverse network of federally-sponsored manufacturing innovation institutes, and is funded through a cooperative agreement with the National Institute of Standards and Technology (NIST) in the U.S. Department of Commerce with significant additional support from its members.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment NIIMBL raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for NIIMBL's next move

See what Strategic adds

NIIMBL raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.